The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease

Use of Low-Dose Aspirin as Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults (from the National Health Interview Survey, 2012)

(2015) Jing Fang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial InfarctionCLINICAL PERSPECTIVE

(2015) Ying Xian et al.   CIRCULATION

Contemporary Patterns of Discharge Aspirin Dosing After Acute Myocardial Infarction in the United States

(2014) Hurst M. Hall et al.  

Discharge Aspirin Dose and Clinical Outcomes in Patients With Acute Coronary Syndromes Treated With Prasugrel Versus Clopidogrel

(2013) Payal Kohli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

(2011) Kenneth W. Mahaffey et al.   CIRCULATION

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

(2011) Sidney C. Smith et al.   CIRCULATION

Aspirin

(2011) Valentin Fuster et al.   CIRCULATION

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified

(2011) Victor Serebruany   THROMBOSIS AND HAEMOSTASIS

Explaining the unexpected: Insights from the PLATelet inhibition and clinical Outcomes (PLATO) trial comparing ticagrelor and clopidogrel

(2011) E. Magnus Ohman et al.   THROMBOSIS AND HAEMOSTASIS

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

(2010) Shamir R Mehta et al.   LANCET

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relation Between Aspirin Dose, All-Cause Mortality, and Bleeding in Patients With Recent Cerebrovascular or Coronary Ischemic Events (from the BRAVO Trial)

(2008) Herbert D. Aronow et al.   AMERICAN JOURNAL OF CARDIOLOGY

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis

(2008) Jeffrey S. Berger et al.   AMERICAN JOURNAL OF MEDICINE